{"id":"https://openalex.org/W3036175486","doi":"https://doi.org/10.1093/europace/euaa162.119","title":"76Causes, safety and outcomes of switching from the Initial direct oral anticoagulant to another in patients with non-valvular atrial fibrillation from a single-center prospective study","display_name":"76Causes, safety and outcomes of switching from the Initial direct oral anticoagulant to another in patients with non-valvular atrial fibrillation from a single-center prospective study","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3036175486","doi":"https://doi.org/10.1093/europace/euaa162.119","mag":"3036175486"},"language":"en","primary_location":{"id":"doi:10.1093/europace/euaa162.119","doi":"https://doi.org/10.1093/europace/euaa162.119","is_oa":false,"landing_page_url":"https://doi.org/10.1093/europace/euaa162.119","pdf_url":null,"source":{"id":"https://openalex.org/S46732370","display_name":"EP Europace","issn_l":"1099-5129","issn":["1099-5129","1532-2092"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EP Europace","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102741359","display_name":"Gabriele Marchetti","orcid":"https://orcid.org/0009-0001-0343-2883","observed_orcids":["https://orcid.org/0009-0001-0343-2883"]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G Marchetti","raw_affiliation_strings":["Ospedale Bellaria AUSL Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Bellaria AUSL Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"middle","author":{"id":null,"display_name":"F Bernardini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F Bernardini","raw_affiliation_strings":["University of Bologna, Psychology, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bologna, Psychology, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075427014","display_name":"Diego Della Riva","orcid":"https://orcid.org/0000-0002-0401-3154","observed_orcids":["https://orcid.org/0000-0002-0401-3154"]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"D Della Riva","raw_affiliation_strings":["Ospedale Bellaria AUSL Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Bellaria AUSL Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033542211","display_name":"Simona Gambetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S Gambetti","raw_affiliation_strings":["Ospedale Bellaria AUSL Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Bellaria AUSL Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030086627","display_name":"Paola Grazi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P Grazi","raw_affiliation_strings":["Ospedale Bellaria AUSL Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Bellaria AUSL Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081101731","display_name":"Giulia Lauria","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G Lauria","raw_affiliation_strings":["Ospedale Bellaria AUSL Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Bellaria AUSL Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013060394","display_name":"Paola Passarelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P Passarelli","raw_affiliation_strings":["Ospedale Bellaria AUSL Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Bellaria AUSL Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027465995","display_name":"Michele Romoli","orcid":"https://orcid.org/0000-0001-8009-8543","observed_orcids":["https://orcid.org/0000-0001-8009-8543"]},"institutions":[{"id":"https://openalex.org/I4210129405","display_name":"Ospedale Infermi di Rimini","ror":"https://ror.org/039bxh911","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210129405"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M Romoli","raw_affiliation_strings":["Ospedale degli Infermi, Medicine, Rimini, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale degli Infermi, Medicine, Rimini, Italy","institution_ids":["https://openalex.org/I4210129405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091846889","display_name":"Alessandra Zaniboni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A Zaniboni","raw_affiliation_strings":["Ospedale Bellaria AUSL Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Bellaria AUSL Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061833973","display_name":"Stefano Urbinati","orcid":"https://orcid.org/0000-0003-3238-9949","observed_orcids":["https://orcid.org/0000-0003-3238-9949"]},"institutions":[{"id":"https://openalex.org/I4210152184","display_name":"Ospedale Bellaria","ror":"https://ror.org/05fz2yc38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210152184"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S Urbinati","raw_affiliation_strings":["Ospedale Bellaria AUSL Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Bellaria AUSL Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210152184"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4344,"currency":"EUR","value_usd":4909},"apc_paid":null,"fwci":0.1619,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.49970927,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"22","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9940000176429749},{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9779999852180481},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.8489999771118164},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.9919999837875366},{"id":"https://openalex.org/keywords/edoxaban","display_name":"edoxaban","score":0.9700000286102295},{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":1.0},{"id":"https://openalex.org/keywords/bleeding-events","display_name":"bleeding events","score":0.46799999475479126},{"id":"https://openalex.org/keywords/ischemic-events","display_name":"ischemic events","score":0.6890000104904175},{"id":"https://openalex.org/keywords/anticoagulation-safety","display_name":"anticoagulant safety","score":0.5770000219345093},{"id":"https://openalex.org/keywords/vitamin-k-antagonists","display_name":"vitamin K antagonists","score":0.675000011920929},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.6679999828338623},{"id":"https://openalex.org/keywords/has-bled-score","display_name":"HAS-BLED score","score":0.6669999957084656},{"id":"https://openalex.org/keywords/cha2ds2-vasc-score","display_name":"CHA2DS2-VASc score","score":0.9380000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9766120910644531},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.951920211315155},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.8815973401069641},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.877662181854248},{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.8513284921646118},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.7222684025764465},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.5803912878036499},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.565406322479248},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.5017361640930176},{"id":"https://openalex.org/C2776704044","wikidata":"https://www.wikidata.org/wiki/Q2852541","display_name":"Vitamin K antagonist","level":4,"score":0.4472441077232361},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4154154658317566},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.38470783829689026},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.10723701119422913}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/europace/euaa162.119","doi":"https://doi.org/10.1093/europace/euaa162.119","is_oa":false,"landing_page_url":"https://doi.org/10.1093/europace/euaa162.119","pdf_url":null,"source":{"id":"https://openalex.org/S46732370","display_name":"EP Europace","issn_l":"1099-5129","issn":["1099-5129","1532-2092"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EP Europace","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3101402335","https://openalex.org/W4247720206","https://openalex.org/W3155593293","https://openalex.org/W2763895023","https://openalex.org/W4366977771","https://openalex.org/W3119217480","https://openalex.org/W3194115802","https://openalex.org/W2902234722","https://openalex.org/W2947843718","https://openalex.org/W4366983407"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Crossover":[2,436],"between":[3,437],"direct":[4],"oral":[5],"anticoagulants":[6,188],"(DOACs)":[7],"in":[8,159,175,308,330,353,360],"real-life":[9],"setting":[10],"has":[11,428],"been":[12],"under":[13],"investigated,":[14],"with":[15,247,304,358],"electronic":[16],"registry-based":[17],"study":[18,30],"missing":[19],"minor":[20,23,259,391,447],"bleedings":[21],"and":[22,44,73,151,225,232,288,323,347,384,399,415,441,449],"ischemic":[24],"events.":[25,387],"The":[26],"purpose":[27],"of":[28,76,211,217,227,249,256,300,310,332,356,376,425],"this":[29],"was":[31,126,136,166,206,239,302],"to":[32,39,67,88,194,200,318,326,335,364],"evaluate":[33],"the":[34,42,45,51,61,240,421],"switch":[35,89,212,257,410],"from":[36,64,120,129,192,198,381],"a":[37,305,429],"DOAC":[38,58,112,131,181,193,199,244],"another":[40,195],"DOAC,":[41,196],"reasons":[43],"clinical":[46],"events":[47,82,85,271,383,406,419,452],"which":[48,427],"happened":[49],"after":[50,245,253,409,446],"switch.":[52],"Methods":[53],"Patients":[54],"(pts)":[55],"receiving":[56,251],"first":[57,130],"prescription":[59,299],"at":[60],"Anticoagulation":[62],"Center":[63],"February":[65],"2018":[66],"September":[68],"2019":[69],"were":[70,90,96,110],"consecutively":[71],"included":[72,258],"followed.":[74],"Causes":[75,255],"switch/dosage":[77],"change":[78,365],"as":[79,81,431,433],"well":[80],"or":[83,163,277],"adverse":[84,270,386,405,418,451],"not":[86],"leading":[87],"registered.":[91],"Results":[92],"Overall,":[93],"300":[94],"pts":[95,109,218,250,359,378],"included,":[97],"mean":[98],"age":[99],"79.3":[100],"\u00b1":[101],"8.5,":[102],"male":[103],"53.7%":[104],"(n":[105,138,144,148,153,261,266,272,279,285,291],"=":[106,139,145,149,154,262,267,273,280,286,292],"161).":[107],"220":[108],"received":[111],"being":[113],"na\u00efve":[114],"(70.7%),":[115],"while":[116,184],"88":[117],"(29.3%)":[118],"transitioned":[119],"vitamin":[121],"K":[122],"antagonists.":[123],"Mean":[124],"follow-up":[125],"1.5":[127],"years":[128],"prescription.":[132],"Most":[133],"prescribed":[134],"DOACs":[135,438],"rivaroxaban":[137,233,322],"107),":[140],"followed":[141],"by":[142],"apixaban":[143],"82),":[146],"edoxaban":[147,231,324],"59)":[150],"dabigatran":[152,220,301,361],"52).":[155],"No":[156],"significant":[157,351],"differences":[158,352],"age,":[160,344],"gender,":[161],"CHA2DS2VASc":[162,346],"HASBLED":[164,348],"score":[165],"detected.":[167],"Throughout":[168],"follow-up,":[169],"61":[170],"patients":[171,179,186],"(20.3%)":[172],"needed":[173],"changes":[174],"anticoagulation":[176],"regimen.":[177],"24":[178],"changed":[180,187],"dosage":[182],"(8%),":[183],"40":[185],"(13.3%),":[189],"39":[190,377],"switched":[191,221],"1":[197,394],"warfarin.":[201],"Annual":[202],"DOAC-to-DOAC":[203],"switching":[204,311],"rate":[205,430],"15.0%":[207],"(95%CI":[208],"10.8-20.3).":[209],"Prevalence":[210],"varied":[213],"across":[214],"DOACs:":[215],"28.8%":[216],"taking":[219,229,341],"vs":[222],"11.0%,":[223],"10.2%":[224],"9.3%":[226],"those":[228],"apixaban,":[230],"respectively":[234],"(p":[235],"<":[236,370],"0.05).":[237,371],"Apixaban":[238],"most":[241,422],"commonly":[242],"preferred":[243],"switch,":[246,426],"43%":[248],"it":[252],"crossover.":[254],"bleeding":[260,265,414,448],"15),":[263],"major":[264,396],"3),":[268],"non-cardiovascular":[269,385,450],"14),":[274],"drug":[275],"interaction":[276],"surgery":[278],"4),":[281],"renal":[282],"function":[283],"worsening":[284],"2)":[287],"low":[289],"compliance":[290,402],"1).":[293],"Comparative":[294],"risk":[295,309],"analysis":[296],"revealed":[297,350],"that":[298],"associated":[303],"3-fold":[306],"increase":[307],"treatment":[312,336,366],"(OR":[313],"3.59,":[314],"95%CI":[315],"2.09-6.19)":[316],"compared":[317],"other":[319],"DOACs.":[320],"Apixaban,":[321],"seemed":[325],"have":[327],"similar":[328],"profile":[329],"terms":[331],"long-term":[333],"adherence":[334],".":[337,411],"Cox":[338],"regression":[339],"analysis,":[340],"into":[342],"account":[343],"weight,":[345],"scores,":[349],"temporal":[354],"distribution":[355],"crossover,":[357],"more":[362],"likely":[363],"(HR":[367],"2.5,":[368],"p":[369],"After":[372],"switching,":[373],"34":[374],"out":[375],"remained":[379],"free":[380],"cardiovascular":[382,417],"One":[388],"pt":[389],"had":[390,395],"bleeding,":[392,398],"only":[393],"(non-fatal)":[397],"none":[400],"reported":[401],"issues.":[403],"Non-cardiovascular":[404],"completely":[407],"resolved":[408],"Conclusion":[412],"Minor":[413],"non":[416],"are":[420],"common":[423],"causes":[424],"high":[432],"15%":[434],"year.":[435],"seems":[439],"safe,":[440],"might":[442],"therefore":[443],"be":[444],"considered":[445]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2020-06-25T00:00:00"}